Newspaper
Linkedin

News

Recent Press Release

Thrive Bioscience Launches the CellAssist to Provide Imaging, Analytics, and Documentation for Reproducible Cell Culture

Wakefield, Massachusetts, October 5, 2020 — Thrive Bioscience introduces the CellAssist® which enables cell culture researchers to image, analyze, and document all cells, plates, reagents, and workflow details in a centralized database. The CellAssist was developed by Thrive Bioscience, an innovator in cell culture systems, in collaboration with several highly-regarded academic institutions. 

Download Release

News Highlights

  • October 1, 2020 — Thrive Bioscience announces filing of four patent applications for improving cell culture utilizing technologies in the fields of the Internet of Things (IoT), blockchain, image processing and automatic focusing.

 

  • September 1, 2020 — Thrive Bioscience presents at the AI, Big Data, and Digital Health Conference on September 8, 2020.

 

  • June 8, 2020 – Thrive Bioscience presents at the MedInvest Infectious Disease and Immunology Conference on June 15, 2020.

 

  • May 15, 2020 — Thrive Bioscience named one of “50 Fastest Growing Companies of 2020” by Silicon Review.

 

  • March 30, 2020 — Herb Kenny, former Vice President of Global Sales, Scientific Instruments at Thermo Fisher Scientific, joins Thrive Bioscience as Chief Commercial Officer, completing the senior management team for commercializing Thrive Bioscience’s family of products to significantly improve cell culture.

 

  • December 31, 2019 — Thrive Bioscience in December completes first five sales of its CellAssist instrument with shipments to commercial customers in Japan, Korea and the U.S.
  • December 31, 2019 — Thrive Bioscience in December completes first five sales of its CellAssist instrument with shipments to commercial customers in Japan, Korea and the U.S.

 

  • November 1, 2019 — Thrive Bioscience files U.S. patent applications on blockchain and the internet of things (IOT) to cell culture. Thrive’s patent portfolio now consists of over 50 applications related to cell culture of which eight have issued.

 

  • August 9, 2019 — Thrive Bioscience named one of 20 Most Promising Biotech Solution Providers 2019 and one of 20 Best Biotech Companies of 2019 by CIO (Chief Information Officer) Review.

 

  • June 5, 2019 — Jeff Goldman, former R&D Manager at Agilent Technologies, joins Thrive Bioscience as Vice President of Engineering & Manufacturing to oversee the productization and manufacturing of Thrive’s family of cell culture instruments.

 

  • January 1, 2019 — Ira J. Schaefer, Esq., former Partner at Hogan Lovells, joins Thrive Bioscience as Vice President of Intellectual Property to oversee and continue the expansion of Thrive Bioscience’s intellectual property portfolio.
  • September 17, 2018 — Takashi Kiyoizumi, M.D., Ph.D., M.B.A, joins Thrive Bioscience as Executive Vice President of International and Senior Advisor to CEO.

 

  • April 5, 2018 — Thrive Bioscience licenses-in on an exclusive basis from an internationally-recognized research institute, an imaging-related portfolio of eight patent applications of which six have issued. Thrive Bioscience’s patent portfolio now includes 34 patent applications of which seven have issued.
  • July 7, 2016 — Thrive Bioscience announces instruments and services agreement with the Harvard Stem Cell Institute.